Vitamin C, Hydrocortisone, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Analysis of Real-World Application - PubMed (original) (raw)

Vitamin C, Hydrocortisone, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Analysis of Real-World Application

Jane J Litwak et al. J Clin Med. 2019.

Abstract

A recent study suggested mortality benefits using vitamin C, hydrocortisone, and thiamine combination therapy (triple therapy) in addition to standard care in patients with severe sepsis and septic shock. In order to further evaluate the effects of triple therapy in real-world clinical practice, we conducted a retrospective observational cohort study at an academic tertiary care hospital. A total of 94 patients (47 in triple therapy group and 47 in standard care group) were included in the analysis. Baseline characteristics in both groups were well-matched. No significant difference in the primary outcome, hospital mortality, was seen between triple therapy and standard care groups (40.4% vs. 40.4%; p = 1.000). In addition, there were no significant differences in secondary outcomes, including intensive care unit (ICU) mortality, requirement for renal replacement therapy for acute kidney injury, ICU length of stay, hospital length of stay, and time to vasopressor independence. When compared to standard care, triple therapy did not improve hospital or ICU mortality in patients with septic shock. A randomized controlled trial evaluating the effects of triple therapy is necessary prior to implementing vitamin C, hydrocortisone, and thiamine combination therapy as a standard of care in patients with septic shock.

Keywords: hydrocortisone; sepsis; septic shock; thiamine; vitamin C.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1

Figure 1

APACHE (Acute Physiology and Chronic Health Evaluation) intravenous (IV) predicted mortality compared to actual mortality. Actual mortality in triple therapy and standard care groups were the same at 40.4% (p = 1.000).

References

    1. Adhikari N.K., Fowler R., Bhagwanjee S., Rubenfeld G.D. Critical care and the global burden of critical illness in adults. Lancet. 2010;376:1339–1346. doi: 10.1016/S0140-6736(10)60446-1. - DOI - PMC - PubMed
    1. Gaieski D.F., Edwards J.M., Kallan M.J., Carr B.G. Benchmarking the Incidence and Mortality of Severe Sepsis in the United States. Crit. Care Med. 2013;41:1167–1174. doi: 10.1097/CCM.0b013e31827c09f8. - DOI - PubMed
    1. Epstein L. Varying Estimates of Sepsis Mortality Using Death Certificates and Administrative Codes — United States, 1999–2014. MMWR. Morb. Mortal. Wkly. Rep. 2016;65:342–345. doi: 10.15585/mmwr.mm6513a2. - DOI - PubMed
    1. Cheng A.C., West T.E., Limmathurotsakul D., Peacock S.J. Strategies to Reduce Mortality from Bacterial Sepsis in Adults in Developing Countries. PLOS Med. 2008;5:e175. doi: 10.1371/journal.pmed.0050175. - DOI - PMC - PubMed
    1. Baelani I., Jochberger S., Laimer T., Otieno D., Kabutu J., Wilson I., Baker T., Dünser M.W. Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: A self-reported, continent-wide survey of anaesthesia providers. Crit. Care. 2011;15:R10. doi: 10.1186/cc9410. - DOI - PMC - PubMed

LinkOut - more resources